NEW YORK--(BUSINESS WIRE)--Feb. 8, 2006--Callisto Pharmaceuticals, Inc. (AMEX:KAL)(FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, today announced that CEO Dr. Gary S. Jacob has been invited to deliver a presentation outlining the Company's clinical studies and its drug candidates in development at one of the world's leading biotechnology industry gatherings, the BIO CEO & Investor Conference 2006, in New York City, on February 14.
